Petros Pharmaceuticals, Inc.
PTPI
$0.0345
-$0.0015-4.17%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -2.26M | -9.27M | -2.22M | -662.00K | -2.16M |
Total Depreciation and Amortization | -- | 667.30K | 768.30K | 754.70K | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 764.00K | 7.35M | -143.10K | -1.48M | 1.01M |
Change in Net Operating Assets | -164.10K | 2.23M | 824.30K | -278.80K | 16.60K |
Cash from Operations | -1.66M | 965.40K | -771.20K | -1.66M | -1.13M |
Capital Expenditure | -- | -5.40K | -19.10K | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -5.40K | -19.10K | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | 0.00 | -385.50K | -379.80K | -- |
Issuance of Common Stock | 8.71M | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -1.14M | -2.39M | -1.58M | -1.12M |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 8.71M | -1.14M | -2.77M | -1.96M | -1.12M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 7.05M | -184.70K | -3.57M | -3.62M | -2.26M |